Open AccessA Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
Author(s) -
Joseph Tauber,
Barry A. Schechter,
Jason Bacharach,
Toyos MM,
Robert Smyth-Medina,
Sidney L Weiss,
Luchs JI
Publication year - 2018
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s196843
Subject(s) - medicine , ophthalmology , randomized controlled trial , optometry , surgery
[This corrects the article on p. 1921 in vol. 12, PMID: 30323548.].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom